Karyopharm Therapeutics Inc. (KPTI): 55% Management Shakeup.

Name: Karyopharm Therapeutics Inc. (KPTI)

Research Notes:

• Total Number of Executives: 11.

• % of Management Shakeup: 55%.

• Six out of Eleven Executives are Promoted/Appointed AFTER - May 2021.

Notes:
1. May 2021: Richard Paulson, MBA (President and Chief Executive Officer)
2. Feb 2022: Stuart Poulton (Chief Development Officer)
3. Mar 2022: Elhan Webb, CFA (Senior Vice President, Investor Relations)
4. Apr 2022: Reshma Rangwala, MD, PhD (Chief Medical Officer)
5. Sep 2022: Lisa DiPaolo (Chief Human Resources Officer)
6. Oct 2022: James Accumanno, JD (Chief Compliance Officer)